Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02514915 · ClinicalTrials.gov registry record · NA

Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases

A NA study, sponsored by Christopher Wilke.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT02514915 is a NA study that has completed, run by Christopher Wilke. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02514915, a NA study, has completed, sponsored by Christopher Wilke.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The primary goal of this research study is to determine the efficacy of giving pre-operative radiosurgery to patients pending resection of a brain metastasis.

Interventions

  • RADIATION Stereotactic Radiosurgery

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2016-12-01
Est. Completion 2021-07-22
Phase NA

Sponsor

Christopher Wilke

2 total trials

What the Registry Record Tells You About NCT02514915

The ClinicalTrials.gov registry entry for NCT02514915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christopher Wilke, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Stereotactic Radiosurgery is the first listed.

NCT02514915 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02514915 about?

NCT02514915 is a clinical study titled "Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases". The primary goal of this research study is to determine the efficacy of giving pre-operative radiosurgery to patients pending resection of a brain metastasis.

What is the current status of trial NCT02514915?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-12-01. Estimated completion is 2021-07-22.

What interventions are being tested in trial NCT02514915?

The interventions under investigation include: Stereotactic Radiosurgery (RADIATION).

Who is sponsoring clinical trial NCT02514915?

This trial is sponsored by Christopher Wilke, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.